Cardiac Glycoside [EPC]

Cardiac Glycoside [EPC] was reported 71873 times

Drugs of the Cardiac Glycoside [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CARDIOACTIVE DRUG LEVEL BELOW THERAPEUTIC 63 0.9265
1 CARDIOACTIVE DRUG LEVEL DECREASED 148 0.8655
2 CARDIOACTIVE DRUG LEVEL INCREASED 1018 0.7741
3 CARDIOACTIVE DRUG LEVEL ABOVE THERAPEUTIC 128 0.7711
4 CARDIOSPASM 402 0.7204
5 IMMUNISATION 260 0.5991
6 PALMOPLANTAR KERATODERMA 392 0.5407
7 THERAPEUTIC AGENT TOXICITY 1177 0.3526
8 ATRIAL TACHYCARDIA 533 0.2536
9 VENOUS PRESSURE JUGULAR INCREASED 86 0.2369
10 PRURITUS GENITAL 397 0.1684
11 MULTIPLE INJURIES 942 0.1495
12 LEFT ATRIAL DILATATION 183 0.1434
13 SICK SINUS SYNDROME 158 0.1374
14 MITRAL VALVE CALCIFICATION 85 0.1322
15 JUGULAR VEIN DISTENSION 69 0.1217
16 ELECTROCARDIOGRAM ST-T CHANGE 85 0.1201
17 CAROTID ARTERY OCCLUSION 430 0.1177
18 NODAL ARRHYTHMIA 98 0.1138
19 BRADYARRHYTHMIA 182 0.1106
20 RIGHT ATRIAL DILATATION 56 0.1102
21 NODAL RHYTHM 160 0.1093
22 DYSPNOEA PAROXYSMAL NOCTURNAL 78 0.1070
23 DILATATION ATRIAL 118 0.1011
24 AORTIC VALVE SCLEROSIS 74 0.1010
25 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 78 0.0957
26 ISCHAEMIC CARDIOMYOPATHY 290 0.0945
27 SLEEP TERROR 398 0.0944
28 TENSION HEADACHE 406 0.0943
29 ECONOMIC PROBLEM 1393 0.0918
30 HYDROPS FOETALIS 54 0.0881
31 ORTHOPNOEA 275 0.0863
32 DILATATION VENTRICULAR 179 0.0851
33 ECHOCARDIOGRAM ABNORMAL 118 0.0843
34 MITRAL VALVE STENOSIS 55 0.0821
35 ATRIOVENTRICULAR BLOCK FIRST DEGREE 328 0.0756
36 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 58 0.0744
37 VENTRICULAR TACHYCARDIA 1221 0.0739
38 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 155 0.0705
39 TRICUSPID VALVE INCOMPETENCE 555 0.0698
40 COR PULMONALE 66 0.0691
41 BUNDLE BRANCH BLOCK LEFT 280 0.0660
42 MITRAL VALVE INCOMPETENCE 742 0.0655
43 CONDUCTION DISORDER 117 0.0638
44 INTERNATIONAL NORMALISED RATIO INCREASED 1802 0.0631
45 BRASH SYNDROME 88 0.0627
46 PULMONARY VALVE INCOMPETENCE 91 0.0622
47 ACUTE PRERENAL FAILURE 72 0.0622
48 LEFT VENTRICULAR HYPERTROPHY 260 0.0607
49 AORTIC VALVE INCOMPETENCE 254 0.0596
50 RHONCHI 82 0.0593
51 HEPATIC CONGESTION 56 0.0591
52 COLONIC POLYP 97 0.0587
53 ATRIAL FLUTTER 461 0.0577
54 CONGESTIVE CARDIOMYOPATHY 236 0.0566
55 CARDIOMEGALY 696 0.0565
56 BRAIN NATRIURETIC PEPTIDE INCREASED 174 0.0564
57 HAEMORRHAGIC ANAEMIA 247 0.0561
58 IMPLANTABLE DEFIBRILLATOR INSERTION 74 0.0559
59 SUBARACHNOID HAEMORRHAGE 562 0.0551
60 RIGHT VENTRICULAR FAILURE 386 0.0550
61 CARDIAC MURMUR 470 0.0543
62 INTERNATIONAL NORMALISED RATIO DECREASED 219 0.0540
63 BUNDLE BRANCH BLOCK 50 0.0532
64 PULMONARY ARTERIAL PRESSURE INCREASED 85 0.0521
65 LEFT VENTRICULAR DYSFUNCTION 349 0.0521
66 AORTIC STENOSIS 180 0.0516
67 CARDIOVERSION 72 0.0515
68 ATRIOVENTRICULAR BLOCK SECOND DEGREE 153 0.0504
69 INTERNATIONAL NORMALISED RATIO FLUCTUATION 102 0.0493
70 SUPRAVENTRICULAR EXTRASYSTOLES 166 0.0491
71 VENTRICULAR HYPOKINESIA 156 0.0485
72 FACIAL PAIN 431 0.0482
73 BRADYCARDIA 2539 0.0478
74 ELECTROCARDIOGRAM T WAVE ABNORMAL 74 0.0474
75 ARRHYTHMIA SUPRAVENTRICULAR 51 0.0467
76 PROTHROMBIN TIME PROLONGED 277 0.0463
77 RENAL FAILURE CHRONIC 356 0.0463
78 TACHYARRHYTHMIA 114 0.0456
79 ATRIOVENTRICULAR BLOCK COMPLETE 303 0.0452
80 VENTRICULAR HYPERTROPHY 110 0.0438
81 VENTRICULAR EXTRASYSTOLES 455 0.0438
82 OCCULT BLOOD POSITIVE 85 0.0432
83 BUNDLE BRANCH BLOCK RIGHT 198 0.0431
84 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 60 0.0427
85 ISCHAEMIC HEPATITIS 58 0.0423
86 ATRIAL FIBRILLATION 4067 0.0417
87 INTERMITTENT CLAUDICATION 66 0.0416
88 CAROTID ARTERY STENOSIS 145 0.0415
89 TORSADE DE POINTES 324 0.0413
90 PULMONARY HYPERTENSION 856 0.0411
91 ESSENTIAL HYPERTENSION 75 0.0409
92 SINUS BRADYCARDIA 394 0.0407
93 LEFT VENTRICULAR FAILURE 136 0.0395
94 ATRIOVENTRICULAR BLOCK 304 0.0393
95 CARDIAC FAILURE CONGESTIVE 3144 0.0391
96 MITRAL VALVE DISEASE 69 0.0389
97 INTERNATIONAL NORMALISED RATIO ABNORMAL 134 0.0389
98 CARDIAC FAILURE CHRONIC 165 0.0387
99 ALVEOLITIS 54 0.0382
100 RALES 222 0.0382
101 LOWER GASTROINTESTINAL HAEMORRHAGE 282 0.0381
102 ABDOMINAL WALL HAEMATOMA 74 0.0379
103 AORTIC ARTERIOSCLEROSIS 97 0.0377
104 VASCULITIS 439 0.0376
105 VENTRICULAR ARRHYTHMIA 137 0.0374
106 VENTRICULAR FIBRILLATION 411 0.0370
107 LOBAR PNEUMONIA 68 0.0367
108 HYPERKALAEMIA 1280 0.0365
109 VENTRICULAR DYSFUNCTION 94 0.0362
110 CARDIOMYOPATHY 533 0.0360
111 CARDIAC VALVE DISEASE 205 0.0358
112 DIASTOLIC DYSFUNCTION 110 0.0356
113 ELECTROCARDIOGRAM ABNORMAL 279 0.0355
114 RENAL FAILURE ACUTE 1490 0.0351
115 HYPERTENSIVE HEART DISEASE 65 0.0347
116 ATELECTASIS 329 0.0340
117 COMPUTERISED TOMOGRAM ABNORMAL 75 0.0331
118 SINUS NODE DYSFUNCTION 60 0.0327
119 BREATH SOUNDS ABNORMAL 161 0.0326
120 HYPOVOLAEMIA 189 0.0323
121 HEART RATE IRREGULAR 716 0.0317
122 CEREBRAL ATROPHY 126 0.0316
123 BLOOD CHLORIDE DECREASED 81 0.0314
124 CHEST X-RAY ABNORMAL 96 0.0313
125 EJECTION FRACTION DECREASED 483 0.0310
126 CREPITATIONS 92 0.0309
127 EMBOLIC STROKE 108 0.0306
128 SUPRAVENTRICULAR TACHYCARDIA 292 0.0305
129 ORAL INTAKE REDUCED 73 0.0302
130 FAMILY STRESS 93 0.0300
131 PERIPHERAL VASCULAR DISORDER 154 0.0299
132 BLOOD UREA INCREASED 486 0.0290
133 ANOSMIA 420 0.0290
134 UPPER GASTROINTESTINAL HAEMORRHAGE 488 0.0290
135 CARDIAC PACEMAKER INSERTION 172 0.0288
136 AORTIC VALVE STENOSIS 51 0.0286
137 DIVERTICULUM 203 0.0285
138 ATRIAL THROMBOSIS 59 0.0285
139 CARDIAC FAILURE ACUTE 189 0.0283
140 PULMONARY ARTERIAL HYPERTENSION 409 0.0282
141 ANGINA UNSTABLE 182 0.0280
142 MELAENA 615 0.0279
143 ARTERIOSCLEROSIS CORONARY ARTERY 185 0.0279
144 INTRACARDIAC THROMBUS 85 0.0277
145 MYOCARDIAL ISCHAEMIA 315 0.0277
146 COAGULOPATHY 457 0.0274
147 SOCIAL PROBLEM 113 0.0273
148 PERICARDITIS 457 0.0272
149 PULSE ABSENT 129 0.0271
150 HYPERLIPIDAEMIA 323 0.0270
151 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 136 0.0268
152 CORONARY ARTERY DISEASE 807 0.0266
153 ANOREXIA 331 0.0257
154 AZOTAEMIA 102 0.0255
155 TRANSIENT ISCHAEMIC ATTACK 857 0.0254
156 CARDIOGENIC SHOCK 359 0.0250
157 ARTERIOSCLEROSIS 233 0.0247
158 CARDIAC FAILURE 1976 0.0246
159 RETROPERITONEAL HAEMATOMA 54 0.0244
160 MULTI-ORGAN FAILURE 419 0.0242
161 HEART INJURY 60 0.0241
162 FLUID OVERLOAD 351 0.0241
163 EXCORIATION 61 0.0240
164 DYSLIPIDAEMIA 122 0.0240
165 INFUSION SITE INFECTION 55 0.0236
166 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 121 0.0236
167 DIVERTICULUM INTESTINAL HAEMORRHAGIC 53 0.0236
168 ELECTROCARDIOGRAM T WAVE INVERSION 52 0.0235
169 SUBDURAL HAEMATOMA 336 0.0234
170 EXTRASYSTOLES 161 0.0230
171 OXYGEN CONSUMPTION INCREASED 55 0.0230
172 BLOOD POTASSIUM INCREASED 368 0.0226
173 URINE OUTPUT DECREASED 198 0.0226
174 GASTROINTESTINAL HAEMORRHAGE 1884 0.0225
175 CORONARY ARTERY STENOSIS 112 0.0222
176 BENIGN PROSTATIC HYPERPLASIA 115 0.0222
177 STUPOR 71 0.0221
178 VISUAL DISTURBANCE 126 0.0219
179 RETROPERITONEAL HAEMORRHAGE 54 0.0219
180 IRON DEFICIENCY ANAEMIA 202 0.0219
181 PULMONARY CONGESTION 286 0.0217
182 ECCHYMOSIS 148 0.0216
183 ARRHYTHMIA 1019 0.0215
184 LUNG INFILTRATION 190 0.0215
185 NORMOCHROMIC NORMOCYTIC ANAEMIA 64 0.0213
186 PERIPHERAL ISCHAEMIA 87 0.0213
187 CREATININE RENAL CLEARANCE DECREASED 85 0.0212
188 CATHETERISATION CARDIAC 94 0.0212
189 NEPHROGENIC SYSTEMIC FIBROSIS 64 0.0212
190 DIPLOPIA 550 0.0212
191 BLOOD CULTURE POSITIVE 63 0.0210
192 HEART RATE DECREASED 735 0.0209
193 LOSS OF EMPLOYMENT 63 0.0208
194 ABDOMINAL TENDERNESS 103 0.0207
195 MUSCLE TWITCHING 477 0.0207
196 DEVICE INFUSION ISSUE 51 0.0205
197 ACUTE RESPIRATORY FAILURE 388 0.0201
198 HAEMOTHORAX 58 0.0200
199 RENAL CYST 158 0.0199
200 PEPTIC ULCER 66 0.0199
201 DYSPNOEA EXERTIONAL 749 0.0199
202 ISCHAEMIA 91 0.0198
203 ANURIA 170 0.0197
204 SUBDURAL HAEMORRHAGE 54 0.0197
205 OLIGURIA 122 0.0196
206 FAILURE TO THRIVE 102 0.0196
207 PULSELESS ELECTRICAL ACTIVITY 82 0.0196
208 REFUSAL OF TREATMENT BY PATIENT 128 0.0196
209 DUODENAL ULCER HAEMORRHAGE 56 0.0196
210 EXERCISE TOLERANCE DECREASED 112 0.0194
211 ENDOTRACHEAL INTUBATION 53 0.0189
212 SPINAL OSTEOARTHRITIS 166 0.0189
213 HEART VALVE INCOMPETENCE 54 0.0188
214 METABOLIC ENCEPHALOPATHY 56 0.0186
215 DRUG TOXICITY 254 0.0186
216 DIFFICULTY IN WALKING 64 0.0186
217 ANHEDONIA 487 0.0185
218 PLEURAL EFFUSION 1125 0.0185
219 BLOOD PRESSURE DIASTOLIC DECREASED 135 0.0183
220 HYPERCAPNIA 55 0.0182
221 GASTRITIS EROSIVE 85 0.0182
222 DRUG INTERACTION 2888 0.0182
223 ACUTE PULMONARY OEDEMA 102 0.0182
224 ORTHOSTATIC HYPOTENSION 314 0.0180
225 INJURY 1261 0.0179
226 INFUSION SITE HAEMORRHAGE 59 0.0179
227 PROTEIN TOTAL DECREASED 67 0.0178
228 DECUBITUS ULCER 145 0.0178
229 DRUG LEVEL INCREASED 294 0.0177
230 PHARMACEUTICAL PRODUCT COMPLAINT 460 0.0177
231 PULMONARY OEDEMA 793 0.0177
232 STAPHYLOCOCCAL SEPSIS 87 0.0176
233 PRESYNCOPE 425 0.0175
234 RESPIRATORY ACIDOSIS 68 0.0173
235 POTENTIATING DRUG INTERACTION 58 0.0173
236 HAEMODIALYSIS 145 0.0172
237 CEREBROVASCULAR DISORDER 52 0.0172
238 HAEMATOMA 445 0.0172
239 CARDIAC FLUTTER 111 0.0172
240 HYPOXIA 604 0.0171
241 SUDDEN CARDIAC DEATH 58 0.0170
242 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 885 0.0169
243 DUODENITIS 52 0.0169
244 HEART RATE ABNORMAL 94 0.0168
245 OEDEMA PERIPHERAL 2039 0.0167
246 BLOOD CREATINE INCREASED 74 0.0167
247 HAEMATURIA 571 0.0167
248 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 68 0.0166
249 BRONCHOPNEUMONIA 57 0.0166
250 NEPHROGENIC ANAEMIA 77 0.0166
251 HAEMATOCRIT DECREASED 328 0.0165
252 CEREBRAL ISCHAEMIA 85 0.0165
253 HAEMORRHAGE INTRACRANIAL 244 0.0163
254 ACUTE MYOCARDIAL INFARCTION 481 0.0163
255 MENTAL STATUS CHANGES 452 0.0163
256 HYPOTENSION 3258 0.0162
257 RENAL FAILURE 2156 0.0162
258 AORTIC ANEURYSM 123 0.0162
259 CARDIAC ARREST 1333 0.0161
260 EPIGASTRIC DISCOMFORT 63 0.0161
261 PAIN OF SKIN 433 0.0161
262 SUDDEN DEATH 170 0.0160
263 HYPERVOLAEMIA 79 0.0160
264 SHOCK HAEMORRHAGIC 130 0.0160
265 PERICARDIAL EFFUSION 369 0.0159
266 CANDIDIASIS 64 0.0159
267 RHINITIS ALLERGIC 71 0.0159
268 CACHEXIA 82 0.0159
269 RECTAL HAEMORRHAGE 684 0.0159
270 CORONARY ARTERY BYPASS 90 0.0156
271 CARDIOPULMONARY FAILURE 61 0.0156
272 HYPERTHYROIDISM 224 0.0155
273 BLOOD PRESSURE SYSTOLIC DECREASED 70 0.0154
274 TROPONIN INCREASED 117 0.0154
275 BLOOD ALBUMIN DECREASED 121 0.0152
276 LUNG NEOPLASM 65 0.0152
277 RASH PAPULAR 341 0.0152
278 HYPOMAGNESAEMIA 210 0.0151
279 SINUS TACHYCARDIA 214 0.0151
280 CYANOSIS 236 0.0150
281 HAEMOPTYSIS 418 0.0150
282 HYPONATRAEMIA 844 0.0150
283 INFUSION SITE PAIN 193 0.0150
284 TOXICITY TO VARIOUS AGENTS 2509 0.0149
285 LIP SWELLING 495 0.0148
286 HEART RATE INCREASED 1459 0.0147
287 CLOSTRIDIUM DIFFICILE COLITIS 156 0.0147
288 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 130 0.0147
289 DEHYDRATION 1954 0.0146
290 RESPIRATORY FAILURE 1066 0.0146
291 HAEMORRHAGIC STROKE 113 0.0145
292 FLUID RETENTION 736 0.0145
293 EMPHYSEMA 145 0.0144
294 OEDEMA 778 0.0143
295 UNRESPONSIVE TO STIMULI 367 0.0142
296 CORONARY ARTERIAL STENT INSERTION 72 0.0142
297 DUODENAL ULCER 100 0.0142
298 LEUKOCYTOSIS 256 0.0141
299 DIABETIC NEUROPATHY 70 0.0141
300 PALPITATIONS 1645 0.0140
301 MALNUTRITION 157 0.0140
302 HEPARIN-INDUCED THROMBOCYTOPENIA 69 0.0140
303 INTESTINAL ISCHAEMIA 77 0.0140
304 FEAR 374 0.0139
305 GASTRIC ULCER HAEMORRHAGE 77 0.0139
306 SYNCOPE 1390 0.0139
307 CARDIO-RESPIRATORY ARREST 580 0.0139
308 INFUSION SITE SWELLING 87 0.0138
309 HIATUS HERNIA 179 0.0138
310 HAEMOGLOBIN INCREASED 63 0.0138
311 TACHYCARDIA 1210 0.0136
312 HYPOKALAEMIA 627 0.0136
313 BLOOD CREATININE INCREASED 884 0.0135
314 INFUSION SITE ERYTHEMA 114 0.0135
315 LACERATION 127 0.0135
316 ABNORMAL LOSS OF WEIGHT 92 0.0135
317 HYPOVOLAEMIC SHOCK 64 0.0133
318 STOMACH DISCOMFORT 69 0.0133
319 SPINAL COLUMN STENOSIS 63 0.0133
320 DIZZINESS POSTURAL 129 0.0133
321 GENERALISED OEDEMA 164 0.0132
322 ACIDOSIS 101 0.0132
323 ELECTROLYTE IMBALANCE 153 0.0132
324 HEPATOMEGALY 129 0.0131
325 RESPIRATORY DISTRESS 362 0.0131
326 BLINDNESS 532 0.0130
327 CARDIAC TAMPONADE 62 0.0130
328 UROSEPSIS 120 0.0130
329 HAEMODYNAMIC INSTABILITY 99 0.0130
330 GOUT 233 0.0130
331 SOCIAL AVOIDANT BEHAVIOUR 75 0.0129
332 EYE PRURITUS 435 0.0129
333 ISCHAEMIC STROKE 231 0.0129
334 CIRCULATORY COLLAPSE 220 0.0129
335 EPISTAXIS 964 0.0129
336 TRANSFUSION 135 0.0129
337 MULTIPLE MYELOMA 60 0.0129
338 HAEMATEMESIS 325 0.0128
339 CARDIAC DISORDER 1194 0.0127
340 SLEEP APNOEA SYNDROME 243 0.0127
341 COGNITIVE DISORDER 594 0.0127
342 BLOOD LACTIC ACID INCREASED 67 0.0127
343 CEREBRAL HAEMORRHAGE 455 0.0127
344 ANGIOEDEMA 562 0.0127
345 HAEMORRHOIDAL HAEMORRHAGE 62 0.0127
346 DRUG LEVEL ABOVE THERAPEUTIC 58 0.0126
347 STAPHYLOCOCCAL BACTERAEMIA 55 0.0126
348 MYOCARDIAL INFARCTION 2199 0.0126
349 DERMATITIS EXFOLIATIVE 63 0.0126
350 ENDOCARDITIS 64 0.0125
351 UNEVALUABLE EVENT 943 0.0125
352 HYPERCHOLESTEROLAEMIA 120 0.0124
353 ANGINA PECTORIS 356 0.0124
354 GASTRIC ULCER 236 0.0124
355 DIVERTICULUM INTESTINAL 54 0.0123
356 VASCULAR DEVICE INFECTION 56 0.0123
357 METABOLIC ACIDOSIS 394 0.0123
358 ASCITES 361 0.0123
359 RESPIRATORY RATE INCREASED 109 0.0123
360 CHEST PAIN 2269 0.0122
361 LOW BIRTH WEIGHT BABY 97 0.0122
362 BLOOD SODIUM DECREASED 230 0.0122
363 CORONARY ARTERY OCCLUSION 167 0.0122
364 FAECES DISCOLOURED 264 0.0122
365 RENAL INJURY 360 0.0121
366 DIALYSIS 171 0.0120
367 HALLUCINATION 904 0.0120
368 FLANK PAIN 112 0.0119
369 BLOOD PRESSURE DECREASED 780 0.0117
370 HEMIPARESIS 198 0.0117
371 ANAEMIA 2211 0.0116
372 INTERNAL HAEMORRHAGE 132 0.0115
373 NOCTURIA 139 0.0114
374 TINNITUS 523 0.0114
375 ELECTROCARDIOGRAM QT PROLONGED 409 0.0114
376 HYPOGLYCAEMIA 551 0.0113
377 FEMORAL NECK FRACTURE 58 0.0113
378 ACUTE KIDNEY INJURY 1727 0.0113
379 CEREBRAL INFARCTION 275 0.0112
380 LETHARGY 647 0.0112
381 HYPERNATRAEMIA 56 0.0112
382 POLYURIA 91 0.0111
383 CELLULITIS 559 0.0111
384 AMNESIA 721 0.0111
385 GASTRITIS 291 0.0110
386 FAECAL INCONTINENCE 53 0.0110
387 LIVER FUNCTION TEST ABNORMAL 320 0.0110
388 PRODUCTIVE COUGH 525 0.0110
389 DYSPNOEA 6220 0.0110
390 DISORIENTATION 434 0.0109
391 CONFUSIONAL STATE 1763 0.0109
392 OESOPHAGITIS 119 0.0109
393 BLOOD ALKALINE PHOSPHATASE INCREASED 270 0.0109
394 ACUTE CORONARY SYNDROME 90 0.0109
395 ASPIRATION 119 0.0109
396 GLOMERULAR FILTRATION RATE DECREASED 133 0.0108
397 ABASIA 266 0.0108
398 CHOLECYSTITIS 128 0.0107
399 TACHYPNOEA 146 0.0107
400 PNEUMONIA ASPIRATION 267 0.0107
401 OXYGEN SATURATION DECREASED 599 0.0106
402 RENAL IMPAIRMENT 894 0.0106
403 DIABETES MELLITUS INADEQUATE CONTROL 188 0.0106
404 BLOOD URIC ACID INCREASED 61 0.0106
405 MOUTH HAEMORRHAGE 77 0.0105
406 HYPOPHAGIA 268 0.0105
407 BLOOD PRESSURE INADEQUATELY CONTROLLED 63 0.0105
408 APNOEA 81 0.0104
409 HEAD INJURY 329 0.0104
410 VARICOSE VEIN 53 0.0103
411 ANEURYSM 51 0.0102
412 DISTURBANCE IN ATTENTION 552 0.0102
413 PULMONARY HAEMORRHAGE 80 0.0102
414 HAEMOGLOBIN DECREASED 1049 0.0102
415 PAIN IN JAW 288 0.0102
416 GASTROENTERITIS 148 0.0101
417 CHOLECYSTITIS ACUTE 57 0.0100
418 DELIRIUM 349 0.0100
419 CONCOMITANT DISEASE AGGRAVATED 62 0.0100
420 SOPOR 133 0.0100
421 WALKING AID USER 66 0.0100
422 BLOOD PRESSURE SYSTOLIC INCREASED 195 0.0100
423 CHOLELITHIASIS 327 0.0100
424 PETECHIAE 103 0.0099
425 ACTIVITIES OF DAILY LIVING IMPAIRED 195 0.0098
426 HAEMORRHOIDS 191 0.0098
427 GANGRENE 59 0.0098
428 HYPERGLYCAEMIA 356 0.0098
429 ASTHENIA 3660 0.0097
430 SKIN ULCER 251 0.0097
431 SEPSIS 1082 0.0097
432 PULMONARY FIBROSIS 186 0.0097
433 PERIPHERAL COLDNESS 133 0.0097
434 TOXIC EPIDERMAL NECROLYSIS 145 0.0095
435 MEDICATION ERROR 530 0.0095
436 DEMENTIA 264 0.0094
437 ARTERIAL OCCLUSIVE DISEASE 74 0.0094
438 SPLENOMEGALY 110 0.0094
439 BLOOD URINE PRESENT 177 0.0093
440 ULCER HAEMORRHAGE 63 0.0093
441 BLOOD POTASSIUM DECREASED 276 0.0092
442 DIZZINESS 4565 0.0091
443 HEMIPLEGIA 76 0.0091
444 MUSCULOSKELETAL CHEST PAIN 140 0.0090
445 MUSCULAR WEAKNESS 1027 0.0090
446 LACTIC ACIDOSIS 291 0.0090
447 CEREBROVASCULAR ACCIDENT 1518 0.0090
448 SPINAL COMPRESSION FRACTURE 74 0.0089
449 HYPOTHYROIDISM 285 0.0089
450 DEVICE RELATED INFECTION 137 0.0089
451 DECREASED ACTIVITY 96 0.0089
452 FALL 2956 0.0089
453 OBESITY 141 0.0088
454 RIB FRACTURE 182 0.0088
455 SHOCK 203 0.0088
456 BLOOD BILIRUBIN INCREASED 238 0.0088
457 MYOPATHY 76 0.0088
458 GINGIVAL BLEEDING 120 0.0088
459 SPUTUM DISCOLOURED 83 0.0087
460 INGUINAL HERNIA 53 0.0087
461 BLOOD MAGNESIUM DECREASED 75 0.0087
462 BLOOD CALCIUM DECREASED 97 0.0086
463 DERMATITIS CONTACT 98 0.0086
464 PURPURA 76 0.0086
465 PNEUMONIA 2774 0.0086
466 LOSS OF CONSCIOUSNESS 1097 0.0086
467 INTERVERTEBRAL DISC DEGENERATION 79 0.0085
468 COLITIS ISCHAEMIC 57 0.0084
469 BACTERAEMIA 100 0.0084
470 HYPERHIDROSIS 1081 0.0084
471 SEPTIC SHOCK 365 0.0084
472 PALLOR 227 0.0083
473 APHASIA 251 0.0083
474 HYPOTHERMIA 84 0.0083
475 SKIN LACERATION 90 0.0083
476 CARDIAC OPERATION 71 0.0083
477 RENAL TUBULAR NECROSIS 81 0.0082
478 JAUNDICE 222 0.0082
479 MYOSITIS 74 0.0082
480 WHITE BLOOD CELL COUNT INCREASED 316 0.0082
481 DEPRESSED LEVEL OF CONSCIOUSNESS 324 0.0082
482 INCOHERENT 53 0.0082
483 RESPIRATORY ARREST 225 0.0082
484 HEPATITIS ACUTE 53 0.0081
485 BODY HEIGHT DECREASED 87 0.0081
486 POLYP 53 0.0081
487 BLOOD TRIGLYCERIDES INCREASED 143 0.0081
488 PELVIC FRACTURE 63 0.0081
489 DYSURIA 296 0.0080
490 INCONTINENCE 85 0.0080
491 ASPARTATE AMINOTRANSFERASE INCREASED 426 0.0080
492 HYDRONEPHROSIS 60 0.0080
493 END STAGE RENAL DISEASE 146 0.0080
494 PULMONARY MASS 119 0.0080
495 NEUTROPENIC SEPSIS 57 0.0080
496 SMALL INTESTINAL OBSTRUCTION 98 0.0080
497 ENCEPHALOPATHY 195 0.0079
498 EMOTIONAL DISORDER 244 0.0079
499 POST PROCEDURAL HAEMORRHAGE 92 0.0079
500 MYOCLONUS 94 0.0079
501 MACULAR DEGENERATION 94 0.0079
502 HYPOKINESIA 114 0.0078
503 CHEST DISCOMFORT 803 0.0078
504 GASTRIC HAEMORRHAGE 90 0.0078
505 HYPERBILIRUBINAEMIA 81 0.0078
506 DYSARTHRIA 294 0.0078
507 PREMATURE BABY 235 0.0078
508 CONTUSION 750 0.0078
509 HALLUCINATION, VISUAL 164 0.0078
510 URINARY RETENTION 259 0.0078
511 POST PROCEDURAL COMPLICATION 149 0.0078
512 DIABETES MELLITUS 588 0.0077
513 ROTATOR CUFF SYNDROME 99 0.0077
514 EMBOLISM 64 0.0077
515 STAPHYLOCOCCAL INFECTION 254 0.0077
516 TREATMENT NONCOMPLIANCE 421 0.0077
517 HYPERCALCAEMIA 95 0.0077
518 OSTEOARTHRITIS 325 0.0077
519 DECREASED APPETITE 1774 0.0076
520 HEPATIC FAILURE 230 0.0076
521 RHABDOMYOLYSIS 318 0.0076
522 BRONCHITIS 563 0.0076
523 ATAXIA 90 0.0076
524 BLOOD GLUCOSE INCREASED 1427 0.0076
525 WEIGHT DECREASED 2111 0.0076
526 URINARY INCONTINENCE 224 0.0076
527 HYPOTONIA 75 0.0075
528 PNEUMOTHORAX 119 0.0075
529 LUNG DISORDER 367 0.0075
530 ANXIETY 2129 0.0075
531 LABORATORY TEST ABNORMAL 219 0.0074
532 ESCHERICHIA INFECTION 61 0.0074
533 MYELODYSPLASTIC SYNDROME 107 0.0074
534 URINARY TRACT INFECTION 1251 0.0073
535 VISUAL IMPAIRMENT 908 0.0073
536 VOMITING 3440 0.0073
537 MULTIPLE ORGAN DYSFUNCTION SYNDROME 207 0.0073
538 BASAL CELL CARCINOMA 114 0.0073
539 PROCEDURAL COMPLICATION 56 0.0073
540 NO THERAPEUTIC RESPONSE 89 0.0073
541 BLOOD CALCIUM INCREASED 64 0.0073
542 HEPATIC CIRRHOSIS 137 0.0073
543 OSTEOPENIA 110 0.0072
544 ALTERED STATE OF CONSCIOUSNESS 156 0.0072
545 TENDERNESS 75 0.0072
546 STENT PLACEMENT 58 0.0072
547 HIP FRACTURE 231 0.0072
548 PERIPHERAL SWELLING 1106 0.0072
549 LUNG INFECTION 111 0.0071
550 WEIGHT FLUCTUATION 74 0.0071
551 LOCALISED INFECTION 171 0.0071
552 HAEMARTHROSIS 63 0.0070
553 CHROMATURIA 157 0.0069
554 HAEMORRHAGE 727 0.0069
555 GROIN PAIN 61 0.0069
556 HYPOALBUMINAEMIA 54 0.0069
557 BRONCHOSPASM 99 0.0069
558 ALANINE AMINOTRANSFERASE INCREASED 425 0.0069
559 EYE HAEMORRHAGE 92 0.0069
560 HYPERTENSION 1458 0.0069
561 PNEUMONIA BACTERIAL 62 0.0067
562 BLOOD LACTATE DEHYDROGENASE INCREASED 107 0.0067
563 NEPHROPATHY 63 0.0067
564 THROMBOCYTOPENIA 754 0.0067
565 BODY TEMPERATURE DECREASED 66 0.0067
566 ATRIAL SEPTAL DEFECT 56 0.0067
567 BACK PAIN 1552 0.0067
568 DISSEMINATED INTRAVASCULAR COAGULATION 94 0.0067
569 POLLAKIURIA 278 0.0067
570 HYPERSOMNIA 191 0.0067
571 HYPOCALCAEMIA 126 0.0067
572 ILL-DEFINED DISORDER 403 0.0066
573 INCREASED TENDENCY TO BRUISE 61 0.0066
574 BEDRIDDEN 87 0.0066
575 GENERAL PHYSICAL HEALTH DETERIORATION 765 0.0066
576 COLD SWEAT 116 0.0066
577 CARDIOVASCULAR DISORDER 167 0.0066
578 SEASONAL ALLERGY 93 0.0066
579 CONVULSION 375 0.0066
580 GAMMA-GLUTAMYLTRANSFERASE INCREASED 145 0.0065
581 ILEUS 81 0.0065
582 DYSPHAGIA 618 0.0065
583 MEMORY IMPAIRMENT 892 0.0065
584 DYSSTASIA 187 0.0064
585 INTENTIONAL PRODUCT MISUSE 560 0.0064
586 MUSCLE ATROPHY 81 0.0064
587 TYPE 2 DIABETES MELLITUS 215 0.0064
588 COMA 304 0.0064
589 WHEEZING 378 0.0064
590 PANCYTOPENIA 355 0.0063
591 UPPER RESPIRATORY TRACT INFECTION 293 0.0063
592 RESPIRATORY DISORDER 189 0.0063
593 PNEUMONITIS 172 0.0063
594 DEFORMITY 59 0.0063
595 BALANCE DISORDER 542 0.0063
596 RENAL DISORDER 290 0.0062
597 SINUS CONGESTION 84 0.0062
598 NECK PAIN 345 0.0062
599 PREMATURE DELIVERY 98 0.0061
600 NAUSEA 4861 0.0061
601 ABDOMINAL DISCOMFORT 1026 0.0061
602 MUSCULOSKELETAL DISCOMFORT 105 0.0061
603 DIVERTICULITIS 169 0.0061
604 ORAL CANDIDIASIS 80 0.0061
605 PSEUDOMONAS INFECTION 52 0.0061
606 COUGH 1697 0.0060
607 BLOOD PRESSURE FLUCTUATION 145 0.0060
608 COLON CANCER 90 0.0060
609 DIARRHOEA 3898 0.0060
610 PROSTATIC SPECIFIC ANTIGEN INCREASED 83 0.0060
611 EXOSTOSIS 55 0.0060
612 BURSITIS 73 0.0060
613 RED BLOOD CELL COUNT DECREASED 172 0.0060
614 HAEMATOCHEZIA 332 0.0060
615 MALAISE 2625 0.0060
616 MIGRAINE 571 0.0060
617 OSTEOMYELITIS 108 0.0060
618 MUSCULOSKELETAL PAIN 312 0.0059
619 ACUTE RESPIRATORY DISTRESS SYNDROME 105 0.0059
620 ABDOMINAL DISTENSION 618 0.0059
621 RETCHING 126 0.0059
622 ULCER 94 0.0059
623 BLOOD IRON DECREASED 70 0.0059
624 CHRONIC KIDNEY DISEASE 447 0.0059
625 LOWER RESPIRATORY TRACT INFECTION 267 0.0059
626 ABDOMINAL PAIN 1362 0.0058
627 LOCAL SWELLING 102 0.0058
628 ABDOMINAL PAIN UPPER 1203 0.0058
629 GASTROOESOPHAGEAL REFLUX DISEASE 465 0.0058
630 HOSPICE CARE 57 0.0058
631 MUSCLE RIGIDITY 69 0.0058
632 OBSTRUCTIVE AIRWAYS DISORDER 64 0.0057
633 INITIAL INSOMNIA 59 0.0057
634 JOINT RANGE OF MOTION DECREASED 77 0.0057
635 PYREXIA 1964 0.0057
636 DRUG PRESCRIBING ERROR 109 0.0057
637 DELUSION 88 0.0057
638 PARALYSIS 81 0.0057
639 RESPIRATORY TRACT INFECTION 147 0.0056
640 CONDITION AGGRAVATED 1711 0.0056
641 VISION BLURRED 767 0.0056
642 FEELING ABNORMAL 1333 0.0056
643 TOXIC SKIN ERUPTION 56 0.0056
644 FLUSHING 564 0.0055
645 CLOSTRIDIUM DIFFICILE INFECTION 121 0.0055
646 DYSPEPSIA 545 0.0055
647 FATIGUE 4287 0.0055
648 SKIN LESION 151 0.0055
649 WOUND INFECTION 60 0.0055
650 JOINT INJURY 117 0.0055
651 RESTLESSNESS 199 0.0054
652 BLOOD THYROID STIMULATING HORMONE INCREASED 50 0.0054
653 PLATELET COUNT DECREASED 578 0.0054
654 BLOOD CREATINE PHOSPHOKINASE INCREASED 156 0.0054
655 VISUAL ACUITY REDUCED 180 0.0054
656 HEPATITIS 138 0.0054
657 AGRANULOCYTOSIS 100 0.0054
658 SKIN DISCOLOURATION 247 0.0054
659 MOTOR DYSFUNCTION 54 0.0053
660 BONE DISORDER 96 0.0053
661 GALLBLADDER DISORDER 94 0.0053
662 DYSPHONIA 307 0.0052
663 INSOMNIA 1398 0.0052
664 BLADDER DISORDER 52 0.0052
665 PARKINSONISM 51 0.0052
666 RESTLESS LEGS SYNDROME 95 0.0052
667 ACCIDENTAL OVERDOSE 191 0.0052
668 STEVENS-JOHNSON SYNDROME 116 0.0052
669 SPEECH DISORDER 273 0.0052
670 EATING DISORDER 110 0.0052
671 MENTAL DISORDER 224 0.0051
672 RESPIRATORY DEPRESSION 63 0.0051
673 NASAL CONGESTION 301 0.0051
674 LIMB INJURY 139 0.0051
675 WOUND 143 0.0051
676 HEPATIC STEATOSIS 95 0.0051
677 POISONING 64 0.0051
678 DEAFNESS 133 0.0051
679 BLOOD PRESSURE ABNORMAL 101 0.0051
680 BACK INJURY 55 0.0051
681 INTENTIONAL PRODUCT USE ISSUE 442 0.0050
682 PAIN IN EXTREMITY 1484 0.0050
683 BLINDNESS UNILATERAL 71 0.0050
684 C-REACTIVE PROTEIN INCREASED 183 0.0050
685 WRIST FRACTURE 60 0.0050
686 THYROID DISORDER 77 0.0050
687 BRAIN OEDEMA 63 0.0050
688 PAIN 3063 0.0050
689 LIVER DISORDER 221 0.0050
690 RESPIRATORY TRACT CONGESTION 79 0.0050
691 DENTAL CARIES 55 0.0050
692 CATARACT 296 0.0050
693 BREAST PAIN 53 0.0050
694 COORDINATION ABNORMAL 69 0.0049
695 CONSTIPATION 1078 0.0049
696 DEEP VEIN THROMBOSIS 321 0.0049
697 EAR PAIN 96 0.0049
698 FLATULENCE 278 0.0049
699 VERTIGO 298 0.0049
700 BLOOD GLUCOSE DECREASED 234 0.0049
701 GAIT DISTURBANCE 931 0.0049
702 CHOLESTASIS 93 0.0048
703 SURGERY 282 0.0048
704 MENTAL IMPAIRMENT 116 0.0048
705 CYSTITIS 152 0.0048
706 PULMONARY THROMBOSIS 52 0.0048
707 BLOOD COUNT ABNORMAL 72 0.0047
708 SEROTONIN SYNDROME 91 0.0047
709 PHOTOPHOBIA 89 0.0047
710 SCAR 81 0.0047
711 THROMBOSIS 380 0.0047
712 MASS 66 0.0047
713 PANCREATITIS ACUTE 106 0.0047
714 INTERSTITIAL LUNG DISEASE 228 0.0047
715 FOETAL EXPOSURE DURING PREGNANCY 382 0.0047
716 AGEUSIA 117 0.0047
717 THERAPY NON-RESPONDER 210 0.0047
718 SINUS DISORDER 92 0.0046
719 BLOOD PRESSURE INCREASED 706 0.0046
720 CHOKING 90 0.0046
721 DRY SKIN 615 0.0046
722 SOMNOLENCE 924 0.0046
723 CARPAL TUNNEL SYNDROME 64 0.0046
724 BLOOD GLUCOSE FLUCTUATION 50 0.0046
725 BACTERIAL INFECTION 85 0.0046
726 EMOTIONAL DISTRESS 547 0.0045
727 ERECTILE DYSFUNCTION 116 0.0045
728 ARTHRITIS 354 0.0045
729 PRURITUS GENERALISED 97 0.0045
730 SCAB 51 0.0045
731 NEUROLEPTIC MALIGNANT SYNDROME 53 0.0045
732 PRESCRIBED UNDERDOSE 89 0.0045
733 NEPHROLITHIASIS 204 0.0044
734 AGITATION 325 0.0044
735 DRY MOUTH 359 0.0044
736 SWELLING 412 0.0044
737 PULMONARY EMBOLISM 417 0.0044
738 ORAL PAIN 98 0.0044
739 BLISTER 245 0.0044
740 GLYCOSYLATED HAEMOGLOBIN INCREASED 110 0.0044
741 CYST 54 0.0043
742 HEADACHE 2705 0.0043
743 PHOTOSENSITIVITY REACTION 71 0.0043
744 IMPAIRED HEALING 141 0.0043
745 ERUCTATION 83 0.0043
746 OVERDOSE 923 0.0043
747 DISEASE PROGRESSION 505 0.0043
748 FULL BLOOD COUNT DECREASED 86 0.0043
749 RASH GENERALISED 110 0.0042
750 RHINORRHOEA 274 0.0042
751 OSTEOPOROSIS 174 0.0042
752 ADVERSE DRUG REACTION 379 0.0042
753 LYMPHOMA 65 0.0042
754 BLOOD CHOLESTEROL INCREASED 196 0.0042
755 ALOPECIA 825 0.0042
756 DEVICE OCCLUSION 59 0.0042
757 BODY TEMPERATURE INCREASED 85 0.0042
758 GLAUCOMA 80 0.0041
759 VIRAL INFECTION 138 0.0041
760 DEPRESSION 937 0.0041
761 PHARYNGITIS 51 0.0041
762 ARTHRALGIA 1709 0.0041
763 HEPATIC FUNCTION ABNORMAL 153 0.0041
764 APHONIA 57 0.0041
765 WEIGHT INCREASED 913 0.0041
766 JOINT SWELLING 490 0.0041
767 GASTRIC DISORDER 139 0.0040
768 TRANSAMINASES INCREASED 90 0.0040
769 GASTROENTERITIS VIRAL 73 0.0040
770 DEATH 3469 0.0040
771 INTERVERTEBRAL DISC PROTRUSION 88 0.0040
772 QUALITY OF LIFE DECREASED 54 0.0040
773 SCIATICA 64 0.0040
774 CHILLS 469 0.0040
775 BLOOD TEST ABNORMAL 56 0.0040
776 DRUG ADMINISTRATION ERROR 122 0.0040
777 RASH MACULO-PAPULAR 88 0.0040
778 MOBILITY DECREASED 284 0.0039
779 FEELING COLD 110 0.0039
780 ABSCESS 63 0.0039
781 DYSGEUSIA 293 0.0039
782 DEVICE FAILURE 60 0.0039
783 MYALGIA 667 0.0039
784 TOOTHACHE 71 0.0039
785 UPPER LIMB FRACTURE 78 0.0039
786 PLATELET COUNT INCREASED 51 0.0039
787 PHARYNGEAL OEDEMA 60 0.0039
788 METASTASES TO BONE 64 0.0039
789 PANCREATITIS 206 0.0039
790 OROPHARYNGEAL PAIN 360 0.0039
791 PARANOIA 67 0.0039
792 NERVOUSNESS 203 0.0039
793 SKIN HAEMORRHAGE 57 0.0038
794 TUBULOINTERSTITIAL NEPHRITIS 72 0.0038
795 DYSKINESIA 156 0.0038
796 ABDOMINAL PAIN LOWER 97 0.0038
797 THROAT IRRITATION 171 0.0038
798 TENDONITIS 59 0.0038
799 TREMOR 630 0.0038
800 FACE OEDEMA 64 0.0038
801 HYPOAESTHESIA ORAL 57 0.0038
802 SWOLLEN TONGUE 118 0.0038
803 ROAD TRAFFIC ACCIDENT 158 0.0038
804 HEPATOTOXICITY 84 0.0038
805 LIVER INJURY 92 0.0037
806 HERNIA 72 0.0037
807 COMPLETED SUICIDE 308 0.0037
808 BONE MARROW FAILURE 75 0.0037
809 COVID-19 646 0.0037
810 SKIN CANCER 79 0.0037
811 FEMUR FRACTURE 113 0.0036
812 HYPOAESTHESIA 546 0.0036
813 SINUSITIS 373 0.0036
814 THIRST 65 0.0036
815 SWELLING FACE 235 0.0036
816 PROTEINURIA 68 0.0036
817 HYPOACUSIS 153 0.0036
818 CANDIDA INFECTION 60 0.0035
819 PARAESTHESIA 555 0.0035
820 NERVOUS SYSTEM DISORDER 110 0.0035
821 LYMPHADENOPATHY 124 0.0035
822 MOVEMENT DISORDER 112 0.0035
823 PRURITUS 1334 0.0035
824 METASTASES TO LIVER 61 0.0035
825 EYE DISORDER 114 0.0035
826 TOOTH DISORDER 77 0.0035
827 NEUROPATHY PERIPHERAL 329 0.0035
828 MUSCLE SPASMS 634 0.0035
829 ARTHROPATHY 192 0.0035
830 MUCOSAL INFLAMMATION 90 0.0034
831 KIDNEY INFECTION 67 0.0034
832 INFECTION 494 0.0034
833 MUSCLE TIGHTNESS 55 0.0034
834 HEAD DISCOMFORT 60 0.0034
835 NIGHT SWEATS 109 0.0034
836 ABNORMAL BEHAVIOUR 134 0.0034
837 COLITIS 128 0.0034
838 ABNORMAL DREAMS 93 0.0034
839 DISEASE RECURRENCE 160 0.0034
840 HERPES ZOSTER 193 0.0034
841 OSTEONECROSIS OF JAW 83 0.0034
842 INTESTINAL OBSTRUCTION 126 0.0033
843 IMPAIRED WORK ABILITY 71 0.0033
844 BONE PAIN 193 0.0033
845 ACUTE MYELOID LEUKAEMIA 51 0.0033
846 RASH PRURITIC 177 0.0033
847 RASH ERYTHEMATOUS 156 0.0033
848 LUNG NEOPLASM MALIGNANT 134 0.0033
849 EOSINOPHILIA 57 0.0032
850 INFLAMMATION 167 0.0032
851 RASH MACULAR 113 0.0032
852 CONTRAINDICATED PRODUCT ADMINISTERED 97 0.0032
853 BLOOD GLUCOSE ABNORMAL 59 0.0032
854 SPINAL FRACTURE 64 0.0032
855 IRRITABLE BOWEL SYNDROME 68 0.0032
856 SEDATION 82 0.0031
857 THINKING ABNORMAL 58 0.0031
858 HEPATIC ENZYME INCREASED 212 0.0031
859 FEEDING DISORDER 63 0.0031
860 MIDDLE INSOMNIA 58 0.0031
861 GASTROINTESTINAL DISORDER 277 0.0031
862 DRUG EXPOSURE DURING PREGNANCY 105 0.0031
863 INFLUENZA 344 0.0031
864 ASTHMA 348 0.0031
865 BACK DISORDER 50 0.0031
866 FEELING HOT 188 0.0031
867 PRODUCT QUALITY ISSUE 416 0.0031
868 FEBRILE NEUTROPENIA 203 0.0031
869 AGGRESSION 153 0.0031
870 MUSCULOSKELETAL DISORDER 58 0.0030
871 SNEEZING 68 0.0030
872 ERYTHEMA 621 0.0030
873 SLEEP DISORDER 213 0.0030
874 FRACTURE 57 0.0030
875 WRONG TECHNIQUE IN DRUG USAGE PROCESS 108 0.0030
876 POOR QUALITY SLEEP 64 0.0030
877 FOOT FRACTURE 56 0.0030
878 EXPOSURE DURING PREGNANCY 183 0.0029
879 PSYCHOTIC DISORDER 86 0.0029
880 DERMATITIS 61 0.0029
881 GLOSSODYNIA 65 0.0029
882 DISCOMFORT 177 0.0029
883 PERITONITIS 60 0.0029
884 LYMPHOCYTE COUNT DECREASED 51 0.0029
885 RASH 1254 0.0029
886 DEVICE DISLOCATION 125 0.0029
887 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 204 0.0029
888 LIMB DISCOMFORT 88 0.0028
889 JOINT STIFFNESS 74 0.0028
890 MUSCULOSKELETAL STIFFNESS 247 0.0028
891 CONJUNCTIVITIS 52 0.0028
892 EYE PAIN 158 0.0028
893 MOUTH ULCERATION 59 0.0028
894 PRODUCT PRESCRIBING ERROR 65 0.0027
895 HOSPITALISATION 415 0.0027
896 SKIN DISORDER 90 0.0027
897 LACRIMATION INCREASED 81 0.0027
898 NEURALGIA 65 0.0027
899 KNEE ARTHROPLASTY 55 0.0026
900 FUNGAL INFECTION 87 0.0026
901 EYE SWELLING 97 0.0026
902 STOMATITIS 158 0.0026
903 HOT FLUSH 196 0.0026
904 EAR INFECTION 69 0.0026
905 DRUG EFFECT DECREASED 139 0.0026
906 THROAT TIGHTNESS 69 0.0025
907 LEUKOPENIA 127 0.0025
908 DRUG INTOLERANCE 245 0.0025
909 NASOPHARYNGITIS 465 0.0025
910 FREQUENT BOWEL MOVEMENTS 68 0.0025
911 VAGINAL HAEMORRHAGE 109 0.0025
912 BURNING SENSATION 175 0.0025
913 NEUTROPENIA 337 0.0025
914 ANAPHYLACTIC SHOCK 63 0.0024
915 PANIC ATTACK 89 0.0024
916 INFLUENZA LIKE ILLNESS 200 0.0024
917 NIGHTMARE 84 0.0024
918 PLASMA CELL MYELOMA 94 0.0024
919 SUICIDE ATTEMPT 146 0.0024
920 INCORRECT PRODUCT ADMINISTRATION DURATION 52 0.0024
921 WHITE BLOOD CELL COUNT DECREASED 260 0.0024
922 ANGER 81 0.0024
923 GYNAECOMASTIA 74 0.0024
924 DEPRESSED MOOD 126 0.0024
925 CRYING 86 0.0024
926 INTENTIONAL OVERDOSE 145 0.0023
927 DRUG DOSE OMISSION 370 0.0022
928 OFF LABEL USE 1929 0.0022
929 MATERNAL EXPOSURE DURING PREGNANCY 195 0.0022
930 INFUSION RELATED REACTION 144 0.0022
931 DRY EYE 108 0.0022
932 NEOPLASM MALIGNANT 143 0.0021
933 PRODUCT USE ISSUE 398 0.0021
934 ECZEMA 110 0.0021
935 GAIT INABILITY 70 0.0021
936 INCORRECT DOSE ADMINISTERED 477 0.0021
937 INCORRECT DRUG ADMINISTRATION DURATION 58 0.0021
938 IRRITABILITY 124 0.0021
939 SEIZURE 237 0.0020
940 OSTEONECROSIS 67 0.0020
941 HYPERSENSITIVITY 377 0.0020
942 DEVICE MALFUNCTION 140 0.0020
943 MALIGNANT NEOPLASM PROGRESSION 200 0.0020
944 BREAST CANCER FEMALE 52 0.0019
945 UNDERDOSE 140 0.0019
946 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 92 0.0019
947 THERAPY CESSATION 98 0.0019
948 ANAPHYLACTIC REACTION 104 0.0019
949 SKIN EXFOLIATION 158 0.0019
950 DRUG EFFECT INCOMPLETE 68 0.0019
951 PRODUCT DOSE OMISSION 122 0.0019
952 ADVERSE EVENT 171 0.0019
953 OCULAR HYPERAEMIA 88 0.0019
954 DRUG INEFFECTIVE 2431 0.0018
955 URTICARIA 304 0.0018
956 EYE IRRITATION 104 0.0018
957 NEUTROPHIL COUNT DECREASED 73 0.0018
958 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 98 0.0018
959 DRUG-INDUCED LIVER INJURY 56 0.0018
960 EPILEPSY 54 0.0018
961 PANCREATIC CARCINOMA 51 0.0018
962 RHEUMATOID ARTHRITIS 197 0.0017
963 PRODUCT USE IN UNAPPROVED INDICATION 429 0.0017
964 INJECTION SITE HAEMORRHAGE 137 0.0017
965 THERAPEUTIC RESPONSE DECREASED 103 0.0017
966 DEVICE LEAKAGE 72 0.0017
967 BONE DENSITY DECREASED 52 0.0017
968 THERAPEUTIC RESPONSE UNEXPECTED 74 0.0016
969 MOOD SWINGS 52 0.0016
970 PRODUCT SUBSTITUTION ISSUE 89 0.0015
971 INCORRECT ROUTE OF DRUG ADMINISTRATION 54 0.0015
972 TREATMENT FAILURE 125 0.0015
973 SYSTEMIC LUPUS ERYTHEMATOSUS 53 0.0015
974 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 298 0.0015
975 ILLNESS 149 0.0014
976 THERAPY INTERRUPTED 103 0.0014
977 SUICIDAL IDEATION 129 0.0014
978 EXTRA DOSE ADMINISTERED 55 0.0014
979 SKIN IRRITATION 60 0.0013
980 BREAST CANCER 119 0.0013
981 DEVICE ISSUE 104 0.0012
982 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 198 0.0011
983 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 77 0.0011
984 SKIN BURNING SENSATION 74 0.0010
985 PROSTATE CANCER 83 0.0010
986 DRUG ABUSE 84 0.0010
987 PSORIASIS 127 0.0010
988 PRODUCT DOSE OMISSION ISSUE 282 0.0010
989 INJECTION SITE ERYTHEMA 110 0.0009
990 BLADDER CANCER 51 0.0009
991 INJECTION SITE PAIN 245 0.0008
992 ACCIDENTAL EXPOSURE TO PRODUCT 75 0.0007
993 INJECTION SITE BRUISING 57 0.0007
994 DRUG WITHDRAWAL SYNDROME 56 0.0006
995 NO ADVERSE EVENT 93 0.0005
996 DRUG DEPENDENCE 63 0.0004